Jason Trusty, PA
Physician Assistant · Charleston, WVNPI 1467566463
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $9,107 of the $10,604 with a category attached, or 85.9%. It is spread thinly across 31 manufacturers, the largest accounting for just 21.8% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in WV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 327 payments — averaging $32.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Novartis$2K
- Regeneron Healthcare Solutions, Inc.$2K
- Sanofi$889
- GSK$675
- AbbVie$499
- plus $3K from 25 others
What the payments were for
- Consulting fees$1,32412%
- Speaking & faculty fees$1251%
- Food & beverage$9,10786%
- Education$480%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 41 | $2,313 |
| Novartis | 24 | $1,985 |
| Regeneron Healthcare Solutions, Inc. | 60 | $1,563 |
| Sanofi | 27 | $889 |
| GSK | 45 | $675 |
| AbbVie | 17 | $499 |
| Genentech USA, Inc. | 16 | $353 |
| Optinose US, Inc. | 16 | $337 |
| Genentech, Inc. | 4 | $299 |
| CSL Behring | 9 | $240 |
| Pfizer | 10 | $190 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $188 |
| Teva Pharmaceuticals USA, Inc. | 12 | $144 |
| Aimmune Therapeutics, Inc. | 1 | $125 |
| Amgen | 6 | $98 |
| Incyte Corporation | 4 | $98 |
| Octapharma USA, Inc. | 1 | $89 |
| Kaleo, Inc. | 5 | $88 |
| Mylan Specialty L.p. | 4 | $85 |
| Pharming Healthcare, Inc. | 2 | $84 |
| Biocryst US Sales Co., LLC | 4 | $62 |
| Lilly USA, LLC | 1 | $33 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $31 |
| Grifols USA, LLC | 1 | $26 |
| Cycle Pharmaceuticals Inc | 1 | $22 |
| Ionis Pharmaceuticals, Inc. | 1 | $21 |
| Arcutis Biotherapeutics, Inc. | 1 | $17 |
| LEO Pharma Inc. | 1 | $17 |
| Merck | 1 | $14 |
| USWM, LLC | 1 | $14 |
| Organon | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,604 in reported general payments places this provider in the 95th percentile of 833 physician assistant providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 54 | $66,160 |
| QnaslBeclomethasone Dipropionate | 34 | $13,985 |
| SymbicortBudesonide/Formoterol Fumarate | 33 | $13,965 |
| Advair HfaFluticasone Propion/Salmeterol | 22 | $12,156 |
| Epinephrine | 36 | $10,182 |
| Azelastine Hcl | 195 | $5,943 |
| Mometasone Furoate | 33 | $4,584 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 106 | $3,958 |
| Bepotastine Besilate | 11 | $3,451 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 15 | $3,396 |
| Fluticasone Propionate | 129 | $2,323 |
| Levocetirizine Dihydrochloride | 109 | $2,146 |
| Montelukast Sodium | 181 | $2,011 |
| Ipratropium Bromide | 38 | $1,859 |
| Levalbuterol Tartrate HfaLevalbuterol Tartrate | 14 | $952 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $675 | $66,16054 claims |
| Teva Pharmaceuticals USA, Inc.Qnasl | $144 | $13,98534 claims |
| AstraZenecaSymbicort | $2,313 | $13,96533 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 833 physician assistant providers in West Virginia.
Other physician assistant in Charleston
- Frances PauleyCharleston$14K
- Danielle MolinaCharleston$12K
- Kelley DotsonCharleston$8K
- Justin ClayCharleston$7K
- Randi DillonCharleston$7K
- Ashley MuellerCharleston$5K
- Yevgeniya GurevichCharleston$5K
- Morgan MeeksCharleston$4K
- Cristina EddyCharleston$4K
- Benjamin ChapmanCharleston$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.